Search Results 511-520 of 16521 for Proliferation
The primary objective of this study is to evaluate mean change in best-corrected visual acuity (BCVA) of RGX-314 relative to ranibizumab at Week 38. Second ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion · Share ...
There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency ( ...
Zaidan A, Bruce KH, Hopkins MR, Robinson SI, Rose CH, VanBuren WM, Langstraat CL. Active surveillance of an endometriosis-related, hormone-responsive pelvic ...
The purpose of this study is to evaluate the probable benefit and safety of the LIPOSORBER® LA-15 System for the treatment of adult and pediatric patients ...
About this study. The purpose of this study is to determine if patients treated with long term maintenance medical therapies have a lowered risk of needing ...
Rochester, Minn. The primary purpose of this study is to assess and describe the contributing sources of discomfort(s) experienced by ICU patients utilizing the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.